STOCK TITAN

CYABRA INC SEC Filings

CYAB NASDAQ
Rhea-AI Summary

CYABRA, INC. Chief Financial Officer Yael Sandler received an equity grant tied to company stock. On May 14, 2026, Sandler was awarded 40,000 restricted stock units under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, vesting over three years through April 1, 2029. Each RSU converts into one share of common stock, giving Sandler 40,000 shares of direct ownership reported after this compensation-related award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Flanagan James Francis reported acquisition or exercise transactions in this Form 4 filing.

CYABRA, INC. director James Francis Flanagan received an equity award in the form of restricted stock units. On May 14, 2026, he was granted 110,000 RSUs under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, with each RSU representing one share of common stock.

The RSUs vest over three years through April 1, 2029, meaning the shares will be delivered gradually as service conditions are met. After this grant, Flanagan’s reported direct holdings from this award total 110,000 shares of common stock-equivalent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Shraga Ido reported acquisition or exercise transactions in this Form 4 filing.

CYABRA, INC. reported that Chief Technology Officer Shraga Ido received an equity compensation grant of 130,000 restricted stock units (RSUs) of common stock on May 14, 2026 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. The RSUs vest in quarterly installments of 26,000 shares of common stock through July 1, 2027, with each RSU representing one share. Following this grant, Ido holds 840,549 shares of common stock directly. The award was granted at a stated price of $0.0000 per share, reflecting a non-cash compensation grant rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

CYABRA, INC. Chief Product Officer Yossef Daar received a grant of 130,000 restricted stock units of common stock as equity compensation. The grant was made at no cash cost per share and increases his directly held position to 840,549 common shares.

The RSUs were issued under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan and vest in quarterly installments of 26,000 shares of common stock through July 1, 2027. Each RSU converts into one share of common stock as it vests, aligning part of the executive’s compensation with future company performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Heymann Emmanuel reported acquisition or exercise transactions in this Form 4 filing.

CYABRA, INC. reported that Chief Revenue Officer Emmanuel Heymann received an equity award in the form of restricted stock units. On May 14, 2026, he was granted 100,000 RSUs under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan, each representing one share of common stock. The RSUs vest over three years through April 1, 2029, aligning a portion of his compensation with the company’s longer-term performance and share price.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Madon Michael P reported acquisition or exercise transactions in this Form 4 filing.

Cyabra, Inc. director Michael P. Madon received an equity grant of 100,000 restricted stock units. The RSUs were awarded on May 14, 2026 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan and carry a grant price of $0.00 per share.

The award vests over three years through April 1, 2029, with each RSU representing the right to receive one share of common stock. Following this grant, Madon holds 100,000 shares or RSUs directly, reflecting compensation rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Brahmy Dan reported acquisition or exercise transactions in this Form 4 filing.

CYABRA, INC. director and Chief Executive Officer Dan Brahmy received a grant of 130,000 shares of common stock on a restricted stock unit basis as equity compensation. The award was recorded at a grant price of $0.00 per share and increased his directly held common stock to 799,402 shares.

The 130,000 restricted stock units vest in quarterly installments of 26,000 shares through July 1, 2027 under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. Each RSU represents the right to receive one share of common stock with a par value of $0.0001.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Vu Sonny reported acquisition or exercise transactions in this Form 4 filing.

CYABRA, INC. director Sonny Vu reported an equity compensation grant and updated holdings. On May 14, 2026, he was granted 80,000 restricted stock units (RSUs) under the Cyabra, Inc. 2026 Omnibus Equity Incentive Plan. These RSUs vest over three years through April 1, 2029, with each RSU representing one share of common stock.

Following the grant, Vu holds 107,329 shares of common stock directly. An additional 273,278 shares are reported as held indirectly by FF Alabaster LLC, a related entity noted in the footnotes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cyabra, Inc. reports first-quarter 2026 results following its March 27 business combination and Nasdaq listing. Revenue rose to $1.4 million from $1.3 million, but net loss widened to $10.8 million from $3.3 million, driven by higher R&D, general and administrative costs, and $5.2 million in stock-based compensation plus $3.4 million of one-time business combination expenses.

Adjusted EBITDA was a loss of $3.2 million. Cash and cash equivalents were $3.1 million as of March 31, 2026, after receiving $8,000 from PIPE financing and merger proceeds. Management states there is substantial doubt about Cyabra’s ability to continue as a going concern without additional financing. Annualized recurring revenue reached $7.0 million, up from $5.9 million a year earlier, reflecting growth in longer-term contracts.

Cyabra also discloses a Nasdaq notice that its market value of listed securities was below $50 million for 30 consecutive business days, triggering a 180-day compliance period ending on November 9, 2026 to regain listing compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.63%
Tags
quarterly report
Rhea-AI Summary

Cyabra, Inc. reported a Schedule 13G/A amendment showing Lowenstein Sandler LLP held 266,000 shares of Common Stock as of May 5, 2026. The amendment states this position represents approximately 1.9% of the outstanding common shares, based on 13,814,167 shares outstanding as of March 27, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many CYABRA (CYAB) SEC filings are available on StockTitan?

StockTitan tracks 24 SEC filings for CYABRA (CYAB), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for CYABRA (CYAB)?

The most recent SEC filing for CYABRA (CYAB) was filed on May 18, 2026.